back
Robert Casson
Robert Casson at WGC-2023
Thursday 29 June 2023 10:30-12:00 CEST Room B
Glaucoma treatment beyond IOP
Chair(s): Robert Casson (Australia); Jonathan Crowston (Singapore);
- Is exercise the exit of glaucoma?
Vicki Chrysostomou (Australia) - NAM and the preclinical evidence Is NAM the hit? Or Is NAM the hit?
Jonathan Crowston (Singapore) - Novel pharmacologic targets
Derek Welsbie (United States) - Metabolic Syndrome and Glaucoma
Gavin Roddy (United States) - Bioenergetic Neuroprotection in Glaucoma
Robert Casson (Australia) - Müller glia, the natural neuroprotectant
Elena Vecino (Spain)
Thursday 29 June 2023 15:30-16:30 CEST Room E
Risk Factors
Chair(s): Francesco Oddone (Italy); Franz Grus (Germany);
- Epidemiological evidence suggesting dietary risk factors in glaucoma
Kelsey Stuart (United Kingdom) - Small molecule energetics and the risk of glaucoma
Robert Casson (Australia) - Lipids and glaucoma: is there a risk?
Simon Nusinovici (Singapore) - Systemic medications which may predispose to glaucoma
Andrew Tatham (United Kingdom) - Social Determinants of Health as Risk Factors for Glaucoma
Nazlee Zebardast (United States)